Comprehensive Pharmacology: Antibacterials and Therapeutic Nursing Applications
Penicillin Antibacterial Agents
The Penicillin class of antibacterials consists of several prominent generic and brand-name medications, including penicillin G procaine (Wycillin), amoxicillin (Amoxil), dicloxacillin sodium (Dynapen), and the combination agent piperacillin-tazobactam (Zosyn). These drugs are utilized for a wide array of susceptible bacterial infections. The specific spectrum of activity is dependent on the individual penicillin selected, but common therapeutic applications include the treatment of respiratory infections, skin and soft-tissue infections, ear and sinus infections, and selected urinary tract infections. Clinical therapy should be guided by culture and susceptibility testing as well as local resistance patterns.
Penicillins function as beta-lactam antibiotics. Their mode of action involves binding to penicillin-binding proteins (PBPs), which results in the inhibition of peptidoglycan cross-linking and the interruption of bacterial cell-wall synthesis. This class is characterized as bactericidal and is most effective against actively dividing susceptible bacteria.
Common and important adverse effects include gastrointestinal (GI) upset and rash. Hypersensitivity reactions are a significant concern, ranging from mild reactions to full-blown anaphylaxis. Patients may also experience superinfections, such as Clostridioides difficile–associated diarrhea. Neurotoxicity and seizures can occur, particularly when high concentrations are reached in the body or in the presence of impaired renal clearance. While rare, severe cutaneous reactions are also possible.
Contraindications and precautions include a history of serious hypersensitivity to the specific penicillin being prescribed. It is vital to inquire about prior immediate or severe reactions to other beta-lactam antibiotics. While renal impairment is not an absolute contraindication, it usually requires dosage adjustments for many penicillins. Clinically important interactions include the drug probenecid, which can increase penicillin concentrations by reducing renal tubular secretion. Certain penicillins may increase the risk of bleeding or anticoagulant effects, and methotrexate clearance may be reduced.
Cephalosporin Antibacterial Agents
Cephalosporins are another major class of beta-lactam antibiotics, with examples including cefadroxil (Duricef), cefazolin sodium (Ancef), cephalexin (Keflex), and cefdinir (Omnicef). They are utilized for susceptible bacterial infections, though the spectrum varies substantially by the cephalosporin generation. Common uses include respiratory, urinary, skin/soft-tissue, bone/joint, and selected central nervous system (CNS) or intra-abdominal infections. Selection should be based on the specific organism, the site of infection, the generation of the drug, and local susceptibility data.
The mode of action for cephalosporins mirrors that of penicillins: they bind to penicillin-binding proteins (PBPs), inhibiting peptidoglycan cross-linking and bacterial cell-wall synthesis. They are bactericidal against susceptible organisms.
Adverse effects include GI upset, rash, and hypersensitivity reactions. Superinfection, including C. difficile–associated diarrhea, is a risk. Anaphylaxis is uncommon but possible, and severe cutaneous reactions are rare. Some agents have unique adverse effects, necessitating a review of individual drug profiles.
Contraindications include serious hypersensitivity to the specific cephalosporin. Notably, a penicillin allergy does not automatically prohibit the use of every cephalosporin; clinical decisions should evaluate the type of prior beta-lactam reaction and the specific cephalosporin in question. Renal dose adjustment is required for many agents in this class. Interactions vary by drug, but there is an increased risk of bleeding or anticoagulant effects with selected agents, and nephrotoxicity risk can increase when used alongside other nephrotoxic drugs.
Macrolide Antibacterial Agents
Macrolides include medications such as azithromycin (Zithromax), clarithromycin (Biaxin), and erythromycin base (E-Mycin). They are primarily used for respiratory tract and selected skin/soft-tissue infections caused by susceptible organisms. They possess important activity against atypical respiratory pathogens. Specifically, azithromycin is employed for certain sexually transmitted infections, including chlamydia.
The mode of action involves binding primarily to the bacterial ribosomal subunit to inhibit protein synthesis. While usually bacteriostatic, macrolides can exhibit bactericidal activity against some organisms depending on the drug and its concentration.
Common adverse effects include GI upset, QT prolongation, and arrhythmia risks, particularly in susceptible patients. Hepatotoxicity and reversible hearing impairment can occur, the latter especially with high exposure. Hypersensitivity and severe skin reactions are uncommon but possible.
Precautions must be taken for patients with a history of QT prolongation, hypokalemia, or hypomagnesemia. Caution is also advised in patients with significant hepatic disease. Clarithromycin, in particular, may require renal adjustment. Drug-drug interactions differ greatly among the class; clarithromycin and erythromycin inhibit and can raise the concentrations of many drugs, including warfarin and digoxin. Azithromycin generally has fewer -mediated interactions.
Tetracycline Antibacterial Agents
Tetracyclines, such as tetracycline (Sumycin), doxycycline (Vibramycin), and minocycline (Minocin), are used for a variety of infections including atypical respiratory infections, acne, skin infections, tick-borne diseases, and chlamydial infections. Doxycycline is specifically used for zoonotic and rickettsial infections. These drugs are not interchangeable for every infection.
The mode of action involves binding to the bacterial ribosomal subunit, which prevents aminoacyl-tRNA attachment and inhibits protein synthesis. They are primarily bacteriostatic.
Significant adverse effects include GI irritation and esophagitis, photosensitivity, and superinfection. A major concern is tooth discoloration and effects on developing bone and teeth; thus, exposure during tooth development should be avoided. Hepatotoxicity is uncommon but possible.
Tetracyclines are contraindicated in cases of hypersensitivity. Routine use during pregnancy should be avoided unless benefits outweigh risks, and age-specific guidance should be followed for children. Older tetracyclines require care in renal impairment, though doxycycline generally does not require renal dose adjustment.
Interactions are critical to manage: aluminum, magnesium, calcium, iron, bismuth, and sucralfate can chelate tetracyclines and reduce absorption. Doses of minerals or antacids should be separated from the medication. Dairy products can also reduce absorption, with the magnitude varying by drug. Warfarin effects may increase in some patients.
Aminoglycoside Antibacterial Agents
Aminoglycosides include amikacin sulfate (Amiken), gentamicin sulfate, and streptomycin sulfate. They are used for serious infections caused primarily by susceptible aerobic gram-negative bacteria, including Pseudomonas. They are often used in combination therapy or synergistically with other drugs for certain gram-positive infections. They are not used as routine monotherapy for MRSA or pelvic inflammatory disease.
These drugs bind irreversibly to the bacterial ribosomal subunit, causing mRNA misreading and inhibiting protein synthesis. They exhibit concentration-dependent bactericidal activity.
Major adverse effects include nephrotoxicity and ototoxicity (both cochlear and vestibular damage). Neuromuscular blockade is rare but serious. Risks increase with higher exposure, prolonged therapy, renal impairment, and concurrent use of other nephrotoxic or ototoxic drugs.
Precautions include monitoring renal function and using therapeutic drug monitoring. Caution is necessary for patients with neuromuscular disorders like myasthenia gravis. In pregnancy, risks are drug-specific; for example, streptomycin can cause fetal ototoxicity. Loop diuretics and drugs like vancomycin or amphotericin B increase the risk of toxicity.
Fluoroquinolone Antibacterial Agents
Fluoroquinolones include ciprofloxacin (Cipro), levofloxacin (Levaquin), and moxifloxacin (Avelox). They treat complicated urinary, GI, respiratory, and bone/joint infections. Ciprofloxacin has strong gram-negative activity, while levofloxacin and moxifloxacin offer greater respiratory activity. Due to serious adverse effect concerns, they are often reserved for when safer alternatives are inappropriate.
The mode of action involves inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, thereby blocking DNA replication and transcription. They are bactericidal agents.
Major warnings and adverse effects include tendinitis, tendon rupture, peripheral neuropathy, CNS effects, and QT prolongation. Dysglycemia and photosensitivity are also possible. Some effects can be disabling or irreversible. Aortic-risk factors should also be considered.
They are contraindicated in patients with myasthenia gravis as weakness may worsen. Renal adjustment is required for several agents. Interactions with products containing aluminum, magnesium, calcium, iron, or zinc can markedly reduce absorption. Ciprofloxacin specifically inhibits , increasing concentrations of caffeine and other drugs.
Sulfonamide Antibacterial Agents
Sulfonamides, including trimethoprim–sulfamethoxazole (TMP-SMX; Bactrim) and sulfadiazine, are used for urinary, respiratory, and GI infections, as well as Pneumocystis jirovecii pneumonia and community-associated MRSA skin infections.
The mode of action involves a dual-step blockade of folate metabolism: sulfamethoxazole competes with PABA to inhibit dihydrofolic acid synthesis, while trimethoprim inhibits dihydrofolate reductase. This combination is generally bactericidal.
Adverse effects include rash, photosensitivity, hyperkalemia (especially from trimethoprim), bone-marrow suppression, and crystalluria. Severe cutaneous reactions like Steven-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN) are rare but serious.
TMP-SMX should be avoided in infants younger than . Interactions include a substantial increase in warfarin effect and increased hyperkalemia risk when used with ACE inhibitors, ARBs, or potassium-sparing diuretics. Methotrexate toxicity and sulfonylurea-associated hypoglycemia risks may also increase.
Nitroimidazole Antibacterial Agents
Metronidazole (Flagyl) is the primary example of this class. It is used for GI tract disorders and, in combination with other agents, for Helicobacter pylori associated with peptic ulcers.
Metronidazole is reduced within anaerobic organisms to reactive intermediates that damage DNA and inhibit nucleic-acid synthesis, exerting a bactericidal effect.
Common effects include nausea, a metallic taste, and dark or reddish-brown urine (harmless). Peripheral neuropathy can occur with prolonged exposure. Patients must avoid alcohol during therapy and for at least afterward due to a potential disulfiram-like reaction. It can also increase warfarin effects and lithium concentrations.
Miscellaneous Antibacterial Classes
Oxazolidinones: Linezolid is used for resistant gram-positive infections like MRSA and VRE. It binds the ribosomal subunit to prevent the formation of the initiation complex. It is generally bacteriostatic. Key risks include thrombocytopenia and serotonin syndrome when used with serotonergic drugs due to weak MAO inhibition.
Lincosamides: Clindamycin is used for anaerobic and gram-positive infections. It binds the subunit. Its most notable adverse effect is C. difficile–associated diarrhea and colitis.
Glycopeptides: Vancomycin is used for serious gram-positive infections including MRSA, and orally for C. difficile. It binds D-Ala-D-Ala precursors to inhibit cell-wall synthesis. It is bactericidal. Side effects include nephrotoxicity and infusion-related reactions from rapid IV administration.
Ketolides: Telithromycin binds the subunit. Its use is now very limited due to risks of severe hepatotoxicity, visual disturbances, and worsening of myasthenia gravis.
Lipopeptides: Daptomycin is used for skin infections, S. aureus bacteremia, and right-sided endocarditis. it inserts into the bacterial membrane and causes rapid depolarization. It is bactericidal but is inactivated by pulmonary surfactant, making it inappropriate for pneumonia. It can cause myopathy and CPK elevation.
Cell Membrane Integrity and Specialized Disruptors
Antibiotics that disrupt cell membrane integrity bind to or insert into the bacterial cell membrane, increasing permeability and leading to the leakage of essential ions, nutrients, and cellular contents, which results in cell death.
Gram-Stain Differences: Gram-positive bacteria have a thick peptidoglycan layer but no outer membrane, allowing drugs to reach the cytoplasmic membrane easily. Gram-negative bacteria possess an outer membrane with lipopolysaccharides (LPS) that act as an additional barrier.
Primary Agents:
Polymyxins: These polypeptides (e.g., Polymyxin B, Colistin) bind to LPS and puncture the membrane. They are used for multidrug-resistant (MDR) Gram-negative infections. Nephrotoxicity must be monitored.
Daptomycin: A cyclic lipopeptide that inserts into the membrane in a calcium-dependent manner, causing depolarization in Gram-positive bacteria.
Polyenes: Examples include Amphotericin B (an antifungal), which creates pores in the membrane by binding to ergosterol. It is the gold standard for severe systemic fungal infections but requires close monitoring of kidney function and electrolytes.
Mnemonic Summary:
"POLY Punctures" (Polymyxins bind LPS and puncture).
"DAPTO Depolarizes" (Daptomycin depolarizes the membrane).
"POLYENES Create Pores" (Polyenes create pores through ergosterol binding).